Indefinite Delivery Contract SPE2DU25D8011

The federal contract IDV award SPE2DU25D8011 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast Guard, and U.S. Naval Fleet. The contract has a 30-month base period and three 30-month option periods, with a total estimated value of $4,999,999.00. It is an unrestricted, fully competitive acquisition focused on providing pharmaceutical (brand, generic, and specialty) and pharmaceutical-related products to support normal day-to-day operations, contingencies, and readiness requirements for CONUS and OCONUS locations. The DLA plans to make multiple primary supplier awards for separate regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) and one award for a backup supplier to ensure resiliency and access to vital pharmaceuticals. Cardinal Health, Inc. has an extensive history of federal contract awards, particularly with the Department of Veterans Affairs, for medical and pharmaceutical supplies.

The original solicitation (ID: bae3e46b4e4c421385f0d20aaf2c4525) for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) was issued by the DLA Troop Support Medical Supply Chain. The solicitation aims to establish prime vendor contracts to provide worldwide pharmaceutical support, with the intent to make multiple awards for separate regions. The contract will cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code (NDC) database, and both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals.